NET

Designing, development and evaluation of anti-thrombogenic factors loaded small diameter vascular graft with superior mechanical and biological properties for cardiovascular tissue reconstruction application. M.Sc, M.Tech, First class Engineering Graduate degree of 4 years in any field of Life Sciences, Biotechnology, Biomedical Engineering.

Post Graduate Degree in Molecular Biology, Biotechnology, Life Sciences, Basic Science OR Graduate, Post Graduate Degree in Professional Course, selected through National Eligibility Tests - CSIR, UGC NET including lectureship Assistant Professorship or GATE.

Development of Microneedle Array Patch Based Haemophilus Influenza Type-B Hib Vaccine Delivery System for Improved Logistics and Better Patient Compliance. First class M.Pharm, M. S. Pharm in Pharmaceutics Pharmaceutical analysis and Pharmacology also will be considered with GATE, GPAT, CSIR UGC-NET including lectureship or equivalent examination.

Development and Evaluation of Dehydrozingerone-Silver sulfadiazine incorporated wound dressings for the effective repair of diabetic wounds. Research work on the synthesis, characterization, and biological evaluation of novel wound dressings and its in-vivo analysis using molecular mechanisms. Proficiency in animal handling, molecular biology techniques and strong communication skills are desirable.

Functionalized s-Heptazine containing materials and their Applications in CO2 Utilization. The main objective of this project is to construct s-Heptazine based systems and their functionalization metal-free and metallated systems for their applications as heterogeneous catalyst in the utilization of CO2 for various value added products like cyclic carbonates, polycarbonates and so on.

Project entitled Development of human iPSCs derived 3D lung organoid as a model for Idiopathic pulmonary fibrosis disease : A potential preclinical platform for screening of anti-fibrosis drug and novel biomarker discovery. M.Sc. in Life Sciences, Biotechnology, Biochemistry, Molecular Biology

M.Sc. Biotechnology, Microbiology or relevant life sciences discipline with a minimum of 55% marks. Minimum experience of two years as researcher. Establishment of synthetic antibody engineering platform for rapid development of indigenous bispecific antibodies to debilitate zoonotic pathogens reducing their pandemic potential.

M.Pharm, MS Pharm, MSc or Equivalent with specialization in Biotechnology, Microbiology or Life sciences. Investigating of the role of LncRNA PANDAR in the progression and metastasis of ovarian cancer. Prior experience in basic techniques in Molecular Biology, Cell culture and Biochemistry are desirable but not mandatory.

BPharm or Post Graduate Degree in Basic, Allied Sciences Biotechnology, Biochemistry, Chemistry, Material Science, Environment Science, Any discipline of Life Sciences OR Graduate, Post Graduate Degree in Professional Course.